Related Experiment Videos
Homeopathic Secretin in autism: a clinical pilot study
1Barton House, Beaminster, Dorset, UK.
The British Homoeopathic Journal
|May 9, 2001
Summary
This pilot study investigated Secretin treatment for autism, finding a worsening of symptoms based on standard assessments. However, anecdotal evidence suggested potential benefits not captured by the scoring system, warranting further research.
Area of Science:
- Neurodevelopmental Disorders
- Gastrointestinal Physiology
Background:
- Autism Spectrum Disorder (ASD) is characterized by social communication deficits.
- The 'opioid excess theory' suggests a role for neuropeptides in autism.
- Previous findings indicated potential benefits of Secretin in improving social and language skills in autistic patients.
Purpose of the Study:
- To pilot the effects of Secretin administration on autistic patients.
- To assess changes in autistic symptoms over a 12-week period.
Main Methods:
- A pilot study involving the administration of Secretin to a group of autistic patients.
- Weekly assessments conducted by care workers over 12 weeks.
- Statistical comparison of pre-treatment and treatment mean scores.
Main Results:
- Statistical analysis indicated a worsening of autistic symptoms during Secretin treatment.
- Care worker discussions revealed unquantifiable improvements and changes not captured by the scoring system.
Conclusions:
- Standardized scoring may not fully capture the effects of Secretin in autism.
- Further research with refined assessment tools is needed.
- A randomized controlled trial comparing Secretin to placebo is recommended.